Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Germany ,Denmark ,Netherlands ,United Kingdom ,Italy ,Geneva ,Genè ,Switzerland ,Luxembourg ,Sweden ,Italian ,Angelini Pharma ,Elodie Causse ,Angelini Group ,Global Campaign Against Epilepsy ,Mental Health ,European Union ,World Health Organization ,Italian Angelini Group ,European Medicines Agency ,Lancet Neurology ,About Angelini ,Rare Diseases ,European Economic Area ,Campaign Against Epilepsy ,Indian Acad ,Epilepsy Curr ,Eurj Neurosci ,Business Wire ,Health ,Business ,Medication ,Europe ,Epilepsy ,